Abstract
Objectives
To evaluate visual performance and factors associated with abnormal vision in patients screened for frailty at the Geriatric Frailty Clinic (GFC) for Assessment of Frailty and Prevention of Disability at Toulouse University Hospital.
Design
Retrospective, observational cross-sectional, single-centre study.
Setting
Institutional practice.
Participants
Patients were screened for frailty during a single-day hospital stay between October 2011 and October 2014 (n = 1648).
Measurements
Collected medical records included sociodemographic data (including living environment and educational level), anthropometric data, and clinical data. The general evaluation included the patient’s functional status using the Activities of Daily Living (ADL) scale and the Instrumental Activity of Daily Living (IADL) scale, the Mini-Mental State Examination (MMSE) for cognition testing, and the Short Physical Performance Battery (SPPB) for physical performance. We also examined Body Mass Index (BMI), the Mini-Nutritional Assessment (MNA), and the Hearing Handicap Inventory for the Elderly Screening (HHIE-S) tool. The ophthalmologic evaluation included assessing visual acuity using the Snellen decimal chart for distant vision, and the Parinaud chart for near vision. Patients were divided into groups based on normal distant/near vision (NDV and NNV groups) and abnormal distant/near vision (ADV and ANV groups). Abnormal distant or near vision was defined as visual acuity inferior to 20/40 or superior to a Parinaud score of 2, in at least one eye. Associations with frailty-associated factors were evaluated in both groups.
Results
The mean age of the population was 82.6 ± 6.2 years. The gender distribution was 1,061 females (64.4%) and 587 males (35.6%). According to the Fried criteria, 619 patients (41.1%) were pre-frail and 771 (51.1%) were frail. Distant and near vision data were available for 1425 and 1426 patients, respectively. Distant vision was abnormal for 437 patients (30.7%). Near vision was abnormal for 199 patients (14%). Multiple regression analysis showed that abnormal distant vision as well as abnormal near vision were independently associated with greater age (P < 0.01), lower educational level (P < 0.05), lower performance on the MMSE (P < 0.001), and lower autonomy (P < 0.02), after controlling for age, gender, educational level, Fried criteria, and MMSE score.
Conclusion
The high prevalence of visual disorders observed in the study population and their association with lower autonomy and cognitive impairment emphasises the need for systematic screening of visual impairments in the elderly. Frailty was not found to be independently associated with abnormal vision.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Frailty is usually defined as a clinical geriatric syndrome characterised by increased “latent vulnerability” resulting from the reduction of physiological reserves and the decreased capacity to cope with exogenous as well as endogenous stressors (1-3). Fried et al. (2) defined frailty as meeting three of the following five criteria: sedentariness or low physical activity, involuntary weight loss, self-reported exhaustion, poor muscle strength, and slow gait speed. Pre-frailty is the term used when two of these criteria are met. Frailty is usually considered a non-definitive state that is amenable to preventive interventions. However, this condition is associated with an increased risk of hospitalisation (2), falls (2, 4), loss of autonomy, institutionalisation (5), cardio-vascular disease (6), and death (2, 5, 7, 8).
According to the United Nations (9), the global population will include approximately 2 billion people older than 60 by 2050. When also taking rising life expectancies into account, the primary public health challenge due to population aging will be to maintain physiological abilities as long as possible to delay the shift from frailty to dependency. Currently, it is estimated that frailty affects approximately one-quarter to one-half of people greater than 85 years old (2, 7). Thus, early and reliable screening to identify those in a pre-disabled or frail state is critical to delay or even prevent adverse outcomes and dependency, as well as the resulting costs of care.
In France, Lafuma et al. (10) estimated the prevalence of visual impairment to be approximately 5.9%, 14.1% and 23.1% among those ranging in age from 70–79 years, 80–89 years, and 90–99 years, respectively. In western European countries, the most frequent causes of visual impairment among the elderly are age-related macular degeneration, uncorrected refractive errors (11), cataract, and glaucoma (12).
In general, even a moderate visual impairment has been shown to be a risk factor for injurious accidents, disability, and falling, as well as depression and anxiety (13-17). Visual impairment is one of the main deficiencies leading to activity limitations (18). From a socioeconomic viewpoint, the number of visually impaired persons in France was estimated at 1.27 million in 2006, which amounted to an annual total cost of €10,749 million in non-medical expenses (approximately $12,089 million) (19). This cost may increase in the future. Thus, in the light of previous arguments, frailty detection programs should include strategies to identify visual impairment.
The aim of the present study was to evaluate visual performance and factors associated with abnormal vision in patients screened for frailty among the first 1,648 patients evaluated during the first three years of operation of the Geriatric Frailty Clinic (GFC) for Assessment of Frailty and Prevention of Disability (Centre Hospitalier Universitaire (CHU) de Toulouse, Toulouse, France).
Material and methods
Patients
In this retrospective, observational cross-sectional, single-centre study, we reviewed the medical records of all patients who underwent medical evaluation at the GFC (CHU de Toulouse, Toulouse, France) between its opening date in October 2011 and October 2014.
The GFC is a geriatric day hospital unit of the Gérontopôle of Toulouse, France (20). In a previous paper, Tavassoli et al. (21) described the structure and organisation of the GFC and also reported the main characteristics of the first 1,108 patients evaluated during the initial two years of operation. Each patient, referred by his/her family physician, benefits from a medical assessment (21). The GFC evaluation is then followed by personalised treatment and follow-up with physicians.
Medical evaluation
Collected medical records included sociodemographic data (including living environment and educational level), anthropometric data, and clinical data (medical and surgical history, current treatments, and allergies). Pre-frailty and frailty were defined as meeting two or three of the five Fried criteria (2), respectively, as described in the Introduction.
The assessment also included the administration of several questionnaires/scales to objectively evaluate specific patient capacities (21). These include the patient’s degree of disability using the basic Activities of Daily Living (ADL) scale (22) and the Instrumental Activities of Daily Living (IADL) scale (23), the Mini-Mental State Examination (MMSE) for cognition testing (24), and the Short Physical Performance Battery (SPPB) for testing physical function (25). The assessment also included the Body Mass Index (BMI) (26), the Mini Nutritional Assessment (MNA) (27), and the Hearing Handicap Inventory for the Elderly Screening (HHIE-S) tool (28).
Ophthalmologic evaluation
Ophthalmologic assessments included: visual acuity (VA) measurement and Amsler grid testing. VA was assessed using the Snellen decimal chart for distant vision, and the Parinaud chart for near vision. Presenting VA with patients’ daily optic correction was evaluated, whereas best-corrected VA was not evaluated. Ophthalmologic assessments were conducted by a nurse who received specialised training. Distant vision was considered normal when distant VA was ≥ 20/40 in both eyes, and abnormal when distant VA was < 20/40 in at least one eye. A patient was considered to have low vision when VA in the better eye < 20/60. Mild vision loss was defined as VA < 20/40, but ≥ 20/60. Near vision was considered normal when near VA was equal to Parinaud 2, and abnormal when near VA was worse than Parinaud 2 in at least one eye. Amsler grid testing was considered abnormal when patients described scotoma and/or metamorphopsia.
Analysis
Distant and near vision were analysed separately. For each type of vision (distant vision, DV; near vision, NV), we divided the study population into two groups: those with normal distant vision (NDV) and normal near vision (NNV), and those with abnormal distant vision (ADV) and abnormal near vision (ANV).
Statistical methods
Distributions of Gaussian variables are presented as the means ± standard deviation (SD). Categorical variables were expressed as counts (n) and percentages (%). The χ2-test and t-test were used to examine differences in covariates. A stepwise backward logistic regression was used to identify factors associated with abnormal vision. Two separate models were performed for distant or near vision as the dependent variable, while systematically controlling for age, sex, and Fried criteria. For other covariates, an entry criterion of P < 0.20 (based on univariate Cox analyses) and a removal criterion of P > 0.05 were used for adjustment in the models. All tests were two-sided and were considered statistically significant at P < 0.05. Analyses were performed using STATA® software package (StataCorp LP, College station, TX, USA), version 11.
Results
Patient characteristics
From October 2011 to October 2014, 1,648 patients were screened. The main clinical characteristics of these patients are reported in Table 1. The mean age of the population was 82.6 ± 6.2 years. The gender distribution was 1,061 females (64.4%) and 587 males (35.6%). According to the Fried criteria, 619 patients (41.1%) were pre-frail and 771 (51.1%) were frail. Distant vision was normal for 988 patients (69.3%). Amsler grid testing was abnormal for 246 patients (16.1%).
Patient characteristics according to distant vision status
Distant vision data were available for 1,425 patients, of which 988 patients (69.3%) had normal distant vision, whereas 437 (30.7%) had abnormal vision. Among the 437 patients in the ADV group, 129 patients (9.1%) had unilateral low vision, 215 (15.1%) had mild vision loss, and 93 (6.5%) had bilateral low vision (Table 1). The mean age in the ADV group (83.4 ± 5.9 years) was significantly higher than in the NDV group (80.3 ± 6.4 years; P < 0.001) (Table 2). Compared to patients in the NDV group, those in the ADV group presented with a lower educational level (P < 0.001), a lesser degree of autonomy (P < 0.001), greater cognitive impairment (P < 0.001), a greater degree of frailty (P < 0.001), and showed poorer physical performance (P < 0.001). The ADV group also showed poorer nutrition overall (P < 0.001) and presented more frequently with abnormal near vision (P < 0.001) and abnormal Amsler grid scores (P < 0.001).
Patient characteristics according to near vision status
Near vision data were available for 1,426 patients, of which 1,227 (86%) had normal near vision, whereas 199 (14%) patients had abnormal near vision. The mean age in the ANV group (84.4 ± 5.7 years) was significantly higher than in the NNV group (82.1 ± 6.2 years; P <0.001) (Table 3). Compared to patients in the NNV group, ANV patients presented with lower educational level (P < 0.001), a lesser degree of autonomy (P < 0.001), greater cognitive impairment (P < 0.001), a greater degree of frailty (P < 0.001), and showed poorer physical performance (P < 0.001). The ANV group patients were also more undernourished (P < 0.001), and more frequently presented with abnormal distant vision (P < 0.001) and abnormal Amsler grid test scores (P < 0.001) compared to patients in the NNV group (Table 3). These results were similar to the analysis for distant vision status.
Multivariate analysis focusing on distant vision
Multiple regression analysis showed that abnormal distant vision was independently associated with greater age (P < 0.001), lower educational level (P = 0.044), poorer performance on the MMSE (P < 0.001), and a lesser degree of autonomy (P = 0.018), after controlling for age, gender, educational level, Fried criteria, and MMSE score (Table 4).
Multivariate analysis focusing on near vision
Multiple regression analysis showed that abnormal near vision was independently associated with greater age (P = 0.007), lower educational level (P < 0.001), lower performance on the MMSE (P < 0.001), and a lower degree of autonomy (P = 0.016), after controlling for age, gender, educational level, Fried criteria, and MMSE score (Table 5).
Discussion
During the last decade, gerontological research has focused on more precisely defining the clinical and physiological characteristics of the vulnerable state corresponding to frailty (1-3, 29). Frailty currently affects approximately 25 to 50% of the population greater than 85 years old (2, 7), and frailty risks include a number of medical and social complications that may lead to death (2, 5, 7, 8).
Early preventive measures are needed to moderate or attenuate this functional decline, and to prevent frail patients from experiencing more serious disabilities or even dependency, and the adverse events associated with these states. These preventive measures include first identifying the population at risk (i.e. pre-frail and frail populations), and secondly establishing effective interventions in collaboration with general practitioners and specialists. These are the two primary goals of the GFC, which was established in October 2011 (20, 21). Patients undergo physical performance evaluation, as well as cognitive, nutritional and sensorial assessments. This global testing battery is used to develop a personal prevention plan adapted to each patient, and allows clinicians to take into account all frailty-related factors (21).
The ophthalmologic assessment at the GFC aims to evaluate patients under conditions as similar as possible to the patients’ daily living conditions, and to orientate the patient to his ophthalmologic practitioner if necessary. For this reason, the ophthalmologic examination is not based on best-corrected VA, but rather presenting VA with daily living optical correction. Indeed, using best-corrected VA would have led us to overlook patients with visual impairment due to uncorrected refractive disorders. Moreover, we set the threshold for abnormal vision at a VA of 20/40 based on the Snellen chart, as recommended by Dandona et al (30). This threshold is widely used for assessing fitness for operating a motor vehicle (31), in combination with visual field and contrast sensitivity, and it is also used as a decision threshold for performing cataract surgery (31). Thus, the 20/40 threshold was deemed appropriate to evaluate visual impairment and its relationship with frailty factors.
Our results show a high prevalence of visual disorders among the study population. Indeed, more than one-third of the patients participating in this study demonstrated visual disorders: 531 (34.6%) presented with abnormal distant vision or abnormal near vision. These data are consistent with previous reports (18, 32). Our bivariate analysis showed that, in our population, abnormal vision in the ADV and ANV groups was associated with greater age, lower educational level, a lesser degree of autonomy, cognitive impairment, frailty, poorer physical performance, and poorer nutritional state. Among these characteristics, the multivariate analysis showed that four factors were independently associated with abnormal vision: greater age, lower educational level, cognitive impairment, and a lesser degree of ADL-assessed autonomy. The first independent factor is not surprising as normal aging is characterised by worsening vision (33).
However, it is interesting to observe that cognitive disorders and lower educational level are independently associated with abnormal vision. Indeed, this may be expected as cognitive activities are known to have a positive effect on cognitive status and on patient trajectory (34, 35). Cognitive function was assessed using the MMSE, which comprises visual tasks that would decrease the final score in this study population and thus may have increased the power of the association observed between visual impairment and lower cognitive testing scores.
The observed relationship between educational level and abnormal vision is particularly strong with respect to near vision. Indeed, near vision is required for reading, and reading abilities are correlated with educational level (36). In addition, lower educational level is associated with lower income (37) and low income may have prevented patients from having regular ophthalmologic check-ups and optical correction. Previous work has also shown that autonomy is associated with visual impairment (38). Our results confirm this association for a visual impairment threshold of VA < 20/40, as shown by Daien et al (11).
Frailty was not found to be independently associated with visual disorders. However, our population was composed of only 118 (7.8%) robust patients, whereas 1390 (84.3%) patients were pre-frail or frail. This imbalance in the study population may have decreased the power of our analysis. In addition, we did not consider abnormal vision itself as a frailty criterion, as in some existing frailty scales (2, 39). Instead, we used the Fried frailty criteria, which focus on sarcopenia and physical performance as key indicators of frailty. Our results may have differed had we used the Frailty Risk Index (40, 41), for example, which also considers visual impairment, or by considering additional cognitive, social, or psychological criteria to define frailty.
Several factors previously found to be associated, or not associated, with visual impairment were not included in the present analyses. For examples, the relationship between falls and visual impairment was not studied, although an association between these two factors has been reported in previous studies (42, 43). Furthermore, the effect of socioeconomic status, which includes income and geographical origin, on visual impairment has not been reported consistently in the literature (10, 44-46), and a lack of data prevented us from including this factor in our analysis. Unfortunately, due to the exhaustive general examination of our elderly patients during a single-day stay in hospital, the ophthalmologic evaluation had to be limited and we were unable to obtain best-corrected VA or to collect additional information concerning the aetiology of visual impairment. Thus, the next step in our visual impairment detection strategy at GFC will be to include fundus photography and intraocular pressure measurements using telemedicine tools, such as a portable retinal camera and portable tonometer. Indeed, telemedicine has been proven to be efficient for the screening of retinopathies (47) and this improvement will allow us to systematically investigate the primary aetiologies of visual impairments among the elderly, which include but are not limited to age-related macular degeneration, cataract, and glaucoma. The data will be systematically transferred to the Ophthalmology Department of the CHU de Toulouse for analysis.
Conclusion
Our results show that visual impairment is independently associated with lower educational level, cognitive impairment, and lower ADL-assessed autonomy. Frailty was not found to be independently associated with visual impairment. These results and the high prevalence of visual disorders observed among the study population emphasises the need for systematic screening for visual impairment in elderly in clinical practice as well as in further research field. This idea is consistent with the multi-domain approach developed by Cesari et al. (48), which uses physical exercise, nutrition, and cognitive training as part of an optimised personal prevention plan to avoid or delay disability among the elderly.
Acknowledgements: Publication of this article was not financially supported. The authors declare no financial conflict of interest.
Conflict of interest: No
Ethical Standards: The authors declare that the study procedures comply with the current ethical standards for investigation involving human participants in France.
References
Kamaruzzaman S, Ploubidis GB, Fletcher A and Ebrahim S. A reliable measure of frailty for a community dwelling older population. Health Qual Life Outcomes 2010;8:123.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, Mcburnie MA and Cardiovascular Health Study Collaborative Research G. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56: M146–156
Xue QL. The frailty syndrome: definition and natural history. Clin Geriatr Med 2011;27:1–15.
Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Vellas B, Albarede JL and Grandjean H. Instrumental activities of daily living as a potential marker of frailty: a study of 7364 community-dwelling elderly women (the EPIDOS study). J Gerontol A Biol Sci Med Sci 2001;56: M448–53.
Rockwood K, Howlett SE, Macknight C, Beattie BL, Bergman H, Hebert R, Hogan DB, Wolfson C and Mcdowell I. Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci 2004;59:1310–7.
Sourdet S, Rouge-Bugat ME, Vellas B and Forette F. Frailty and aging. J Nutr Health Aging 2012;16:283–4.
Song X, Mitnitski A and Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc 2010;58:681–7.
Klein BE, Klein R, Knudtson MD and Lee KE. Frailty, morbidity and survival. Arch Gerontol Geriatr 2005;41:141–9.
United-Nations) World Population Prospects: The 2012 Revision. Available from: http://esa.un.org/wpp/Documentation/pdf/WPP2012_HIGHLIGHTS.pdf (accessed August 18, 2014).
Lafuma AJ, Brezin AP, Fagnani FL, Mesbah M and Berdeaux GH. Prevalence of visual impairment in relation to the number of ophthalmologists in a given area: a nationwide approach. Health Qual Life Outcomes 2006;4:34.
Daien V, Peres K, Villain M, Colvez A, Delcourt C and Carriere I. Visual impairment, optical correction, and their impact on activity limitations in elderly persons: the POLA study. Arch Intern Med 2011;171:1206–7.
Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S, Taylor HR and Vision Loss Expert G. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health 2013;1: e339–49.
Kulmala J, Era P, Parssinen O, Sakari R, Sipila S, Rantanen T and Heikkinen E. Lowered vision as a risk factor for injurious accidents in older people. Aging Clin Exp Res 2008;20:25–30.
Knudtson MD, Klein BE and Klein R. Biomarkers of aging and falling: the Beaver Dam eye study. Arch Gerontol Geriatr 2009;49:22–6.
Vu HT, Keeffe JE, Mccarty CA and Taylor HR. Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol 2005;89:360–3.
Anand V, Buckley JG, Scally A and Elliott DB. Postural stability changes in the elderly with cataract simulation and refractive blur. Invest Ophthalmol Vis Sci 2003;44:4670–5.
Evans JR, Fletcher AE and Wormald RP. Depression and anxiety in visually impaired older people. Ophthalmology 2007;114:283–8.
Daien V, Peres K, Villain M, Colvez A, Carriere I and Delcourt C. Visual acuity thresholds associated with activity limitations in the elderly. The Pathologies Oculaires Liees a l’Age study. Acta Ophthalmol 2014. 92: e500–6
Lafuma A, Brezin A, Lopatriello S, Hieke K, Hutchinson J, Mimaud V and Berdeaux G. Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK. Pharmacoeconomics 2006;24:193–205.
Demougeot L, Abellan van Kan G, Vellas B, de Souto Barreto P. FRAILTY Detection with the gerontopole frailty screening tool (GFST). J Frailty Aging 2013;2:150–152
Tavassoli N, Guyonnet S, Abellan Van Kan G, Sourdet S, Krams T, Soto ME, Subra J, Chicoulaa B, Ghisolfi A, Balardy L, Cestac P, Rolland Y, Andrieu S, Nourhashemi F, Oustric S, Cesari M, Vellas B, Geriatric Frailty Clinic (G.F.C) for Assessment of Frailty and Prevention of Disability Team. Description of 1,108 older patients referred by their physician to the «Geriatric Frailty Clinic (G.F.C) for Assessment of Frailty and Prevention of Disability» at the gerontopole. J Nutr Health Aging 2014;18:457–64.
Katz S, Ford AB, Moskowitz RW, Jackson BA and Jaffe MW. Studies of Illness in the Aged. The Index of Adl: A Standardized Measure of Biological and Psychosocial Function. JAMA 1963;185:914–9.
Lawton MP and Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–86.
Folstein MF, Folstein SE and Mchugh PR. «Mini-mental state». A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98.
Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA and Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49: M85–94.
Eknoyan G. Adolphe Quetelet (1796-1874)-the average man and indices of obesity. Nephrol Dial Transplant 2008;23:47–51.
Guigoz Y and Vellas B. The Mini Nutritional Assessment (MNA) for grading the nutritional state of elderly patients: presentation of the MNA, history and validation. Nestle Nutr Workshop Ser Clin Perform Programme 1999;1:3–11.
Sindhusake D, Mitchell P, Smith W, Golding M, Newall P, Hartley D and Rubin G. Validation of self-reported hearing loss. The Blue Mountains Hearing Study. Int J Epidemiol 2001;30:1371–8.
Chin APMJ, Dekker JM, Feskens EJ, Schouten EG and Kromhout D. How to select a frail elderly population? A comparison of three working definitions. J Clin Epidemiol 1999;52:1015–21.
Dandona L and Dandona R. Revision of visual impairment definitions in the International Statistical Classification of Diseases. BMC Med 2006;4:7.
Colenbrander A, De Laey JA. Vision requirements for driving safety. Report for the International Council of Ophthalmology. Sao Paulo 2006.
Evans JR, Fletcher AE, Wormald RP, Ng ES, Stirling S, Smeeth L, Breeze E, Bulpitt CJ, Nunes M, Jones D and Tulloch A. Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol 2002;86:795–800.
Dagnelie G. Age-related psychophysical changes and low vision. Invest Ophthalmol Vis Sci 2013;54: ORSF88–93.
De Frias CM and Dixon RA. Lifestyle engagement affects cognitive status differences and trajectories on executive functions in older adults. Arch Clin Neuropsychol 2014;29:16–25.
Marques Da Silva E, Apolinario D, Miksian Magaldi R, Bennett DA, Nitrini R, Jacob Filho W and Marcelo Farfel J. Learning to read in older age improves cognitive performance: findings from a prospective observational study. J Am Geriatr Soc 2014;62:2218–9.
Silagi ML, Romero VU, Mansur LL and Radanovic M. Inference comprehension during reading: influence of age and education in normal adults. Codas 2014;26:407–14.
Liao CC, Yeh CJ, Lee SH, Liao WC, Liao MY and Lee MC. Providing Instrumental Social Support Is More Beneficial to Reduce Mortality Risk among the Elderly with Low Educational Level in Taiwan: A 12-year Follow-Up National Longitudinal Study. J Nutr Health Aging 2015;19:447–53.
Nakamura K, Otomo A, Maeda A, Kikuchi S, Motohashi Y, Tanaka M, Nakadaira H and Yamamoto M. Evaluation of complex activities in daily living of elderly Japanese with visual impairment. Aging (Milano) 1999;11:123–9.
Rockwood K, Song X, Macknight C, Bergman H, Hogan DB, Mcdowell I and Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005;173:489–95.
Ho YY, Matteini AM, Beamer B, Fried L, Xue QL, Arking DE, Chakravarti A, Fallin MD and Walston J. Exploring biologically relevant pathways in frailty. J Gerontol A Biol Sci Med Sci 2011;66:975–9.
Ng TP, Feng L, Nyunt MS, Larbi A and Yap KB. Frailty in older persons: multisystem risk factors and the Frailty Risk Index (FRI). J Am Med Dir Assoc 2014;15:635–42.
Hong T, Mitchell P, Burlutsky G, Samarawickrama C and Wang JJ. Visual impairment and the incidence of falls and fractures among older people: longitudinal findings from the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 2014;55:7589–93.
Gleeson M, Sherrington C and Keay L. Exercise and physical training improve physical function in older adults with visual impairments but their effect on falls is unclear: a systematic review. J Physiother 2014;60:130–5.
Liu JH, Cheng CY, Chen SJ and Lee FL. Visual impairment in a Taiwanese population: prevalence, causes, and socioeconomic factors. Ophthalmic Epidemiol 2001;8:339–50.
Ulldemolins AR, Lansingh VC, Valencia LG, Carter MJ and Eckert KA. Social inequalities in blindness and visual impairment: a review of social determinants. Indian J Ophthalmol 2012;60:368–75.
Rius A, Artazcoz L, Guisasola L and Benach J. Visual impairment and blindness in spanish adults: geographic inequalities are not explained by age or education. Ophthalmology 2014;121:408–16.
Creuzot-Garcher C, Malvitte L, Sicard AC, Guillaubey A, Charles A, Beiss JN and Bron A. How to improve screening for diabetic retinopathy: the Burgundy experience. Diabetes Metab 2010;36:114–9.
Cesari M, Demougeot L, Boccalon H, Guyonnet S, Vellas B and Andrieu S. The Multidomain Intervention to preveNt disability in ElDers (MINDED) project: rationale and study design of a pilot study. Contemp Clin Trials 2014;38:145–54.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Soler, V., Sourdet, S., Balardy, L. et al. Visual impairment screening at the Geriatric Frailty Clinic for Assessment of Frailty and Prevention of Disability at the Gérontopôle. J Nutr Health Aging 20, 870–877 (2016). https://doi.org/10.1007/s12603-015-0648-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-015-0648-z